JackLeckerman

What JackLeckerman does

JackLeckerman is a privately held business event organizer founded in 2016 and headquartered in Šenkvice, Slovakia, specializing in high-level summits, strategic conferences, open forums, and professional training programs for the pharmaceutical and biotechnology industries. The company's core offering is the Biosimilars LatAm forum series, held across Brazil, Mexico, Colombia, and a Global edition, with the TechPharmaNet conference series (focused on pharma R&D, manufacturing, and laboratory technology) and specialized training programs (e.g., Biosimilar Market Entry in Europe) forming secondary product lines. Events are supported by a proprietary JackLeckerman WebApp and native iOS/Android applications that deliver attendee networking, 1-to-1 meeting scheduling, live polling, translation services, agenda access, and content downloads.

The company makes money through three primary revenue streams: one-time delegate registration fees (priced at $790 for local delegates and $1,300 for international delegates at Brazil 2026, with vendor passes up to $2,400 at Mexico 2022), enterprise sponsorships sold to pharma and biotech supply-chain participants (Thermo Fisher, Sartorius, Merck Group, Amgen, Teva, Bruker, Terumo, INFORS HT among others), and professional training fees for programs such as the Biosimilar Market Entry in Europe course. A multi-year contract tier (Branded Pharmaceutical Manufacturer Pass) introduces subscription-style pricing for repeat enterprise buyers. Customer segments span biosimilar manufacturers, regulatory affairs professionals, government officials and regulators (WHO, EMA, FDA, ANVISA, COFEPRIS, INVIMA, CECMED), investors, academia, and patient representatives.

The operating model is lean, with 9 employees executing a multi-continent event calendar across Europe, Latin America, North America, Africa, and Asia. Go-to-market relies on direct enterprise sales, an industry association referral channel, and multi-channel digital marketing (LinkedIn, Facebook, Twitter, Instagram) supplemented by media partnerships with BioPartner UK and PHARMA NEWS Magazine. The company celebrates its 10-year milestone in 2026, with confirmed upcoming events in Brazil, Mexico, and Egypt.

Name

JackLeckerman

Legal name

JackLeckerman

Website

https://jackleckerman.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

JackLeckerman is a Slovakia-based business event organizer founded in 2016 that produces high-level summits, forums, and training programs for the pharmaceutical and biotechnology industries, with a primary focus on biosimilars across Latin America, Europe, and Africa.

Ownership category

akta.pro rank

Product category

Pharmaceutical Conference Services

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Life Sciences & Biotechnology Congresses (THAHAJAB)

akta.pro secondary industry

Executive Summits & Invitation-Only Forums (MPAGAGAK)

Keywords

• Pharmaceutical event management
• Biosimilars conferences
• Pharma industry forums
• Biotech networking events
• Regulatory affairs summits

Headquarters

HQ city

Šenkvice

HQ country

Slovakia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Event Registration Fees: Registration fees for attending forums and conferences. Multiple attendance tiers exist including vendor/delegate passes (2400, 2100 USD for Mexico 2022; 1300 international/790 local for Brazil 2026). Fees include networking sessions, presentations, materials, and sometimes accommodation.
2. Sponsorship: Sponsorship opportunities for forums where companies can gain visibility, brand exposure, and access to industry decision-makers. Sponsors receive booth spaces, speaking opportunities, and networking access.
3. Speaker Sessions: Professional training programs such as 'Biosimilar Market Entry in Europe' providing practical training for biosimilar manufacturers on regulatory pathways and market entry strategies.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

JackLeckerman organizes strategic forums, summits, open forums, and professional training programs for the global pharmaceutical and biotechnology industries, with a primary focus on biosimilars in Latin America. Its core offerings include the Biosimilars LatAm forum series (Colombia, Brazil, Mexico, Global, Europe, Africa editions), the TechPharmaNet technology-focused conference, and specialized training programs such as Biosimilar Market Entry in Europe, complemented by a proprietary WebApp for attendee networking and meeting scheduling.

Product overview

JackLeckerman is a business event organizer specializing in global summits, strategic conferences, open forums, and professional training programs for the pharmaceutical and biotechnology industries. The company operates three main product lines: the Biosimilars LatAm Forums (covering Colombia, Brazil, Mexico, Global, and Europe editions) addressing biosimilar regulatory harmonization and market access; the TechPharmaNet conference series focused on pharmaceutical technology, R&D, and manufacturing innovation; and specialized training programs like the Biosimilar Market Entry in Europe course. All events are supported by the JackLeckerman Mobile App which enables attendee networking, 1-to-1 meeting scheduling, and content access. In 2026, JackLeckerman celebrates 10 years of operation.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Forum brings together regulators, pharmaceutical leaders, investors, academics, healthcare professionals, and patient representatives to advance biosimilars
• +2 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

20 partnerships are on record, tiered core, major, channel and sponsor.

• SandozcoreStrategic or Co-development PartnerSandoz participates as a key speaker and contributor at JackLeckerman forums, providing expertise on regulatory affairs, market access, and biosimilar development. Representatives include Medical & Regulatory Affairs Director, National Channel Sales Manager, and Regulatory Affairs Manager.
• INVIMA (Colombia)coreStrategic or Co-development PartnerColombia's national food and drug surveillance institute participates in forums as key regulatory authority, contributing to discussions on regulatory harmonization and healthcare sustainability.
• ANVISA (Brazil)coreStrategic or Co-development PartnerBrazil's health regulatory agency contributes speakers and regulatory insights at Brazil forums, providing perspectives on biosimilar registration and market access.
• COFEPRIS (Mexico)coreStrategic or Co-development PartnerMexico's Federal Commission for Protection against Sanitary Risks participates in forums, sharing insights on regulatory certainty strategy and market entry requirements.
• CECMED (Cuba)coreStrategic or Co-development PartnerCuba's regulatory agency participates in forums, contributing perspectives on biosimilar regulation and mutual recognition agreements.
• WHO (World Health Organization)coreStrategic or Co-development PartnerWHO participates as a key speaker and contributor, providing global perspectives on biosimilar policy, standards, and regulatory guidelines.
• EMA (European Medicines Agency)coreStrategic or Co-development PartnerEMA contributes regulatory experts to forums, sharing European experience on biosimilar approval and post-market surveillance.
• FDA (US Food and Drug Administration)coreStrategic or Co-development PartnerFDA participates with scientific reviewers providing US regulatory perspectives on biosimilar development and approval pathways.
• SartoriusmajorStrategic or Co-development PartnerSartorius, a leading biopharmaceutical equipment provider, sponsors forums and provides speakers on bioprocess solutions and manufacturing technologies.
• Thermo Fisher ScientificmajorStrategic or Co-development PartnerMajor sponsor providing speakers on laboratory equipment, analytical services, and pharmaceutical solutions. Supports forum events with exhibition presence.
• mAbxiencemajorStrategic or Co-development PartnermAbxience, a biosimilar manufacturer, participates as speaker and contributor, sharing commercial and market access perspectives for Latin America.
• UDIBImajorTechnology or IntegrationUDIBI is a COFEPRIS-authorized third-party laboratory with 60+ scientists providing analytical services for pharmaceutical industry. Sponsors forums and provides technical expertise.
• BioPartner UKchannelChannel Partner/ Reseller/ DistributorBioPartner UK is an accredited trade organization supporting international trade for UK life science companies. Serves as media partner for UK market reach.
• Merck GroupmajorStrategic or Co-development PartnerMerck Group sponsors forums and provides speakers on biosimilar partnership programs and global strategic excellence initiatives.
• Teva PharmaceuticalsmajorStrategic or Co-development PartnerTeva participates as speaker and contributor, providing perspectives on regulatory affairs, market access, and biosimilar development across Latin America.
• BrukersponsorTechnology or IntegrationBruker provides life science research and diagnostics solutions as a sponsor, showcasing advanced analytical technologies at forums.
• Terumo Pharmaceutical SolutionssponsorTechnology or IntegrationTerumo sponsors forums and provides speakers on pharmaceutical packaging, drug delivery solutions, and parenteral delivery technologies.
• AmgenmajorStrategic or Co-development PartnerAmgen participates as speaker and contributor, providing insights on innovation, competitiveness, and market dynamics in the pharmaceutical sector.
• INFORS HTsponsorTechnology or IntegrationINFORS HT provides bioreactors and bioprocess control software as sponsor, showcasing biotechnology solutions at forums.
• PHARMA NEWS MagazinechannelGTM or Marketing PartnerMexican pharmaceutical industry publication serves as media partner, extending reach to Mexican pharma professionals through their magazine.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Hanson Wade: Hanson Wade is a specialized conference organizer focused on life sciences, biotech, and pharma verticals, frequently running invitation-only forums with regulator and C-level participation. It is highly comparable to JackLeckerman in format (specialized, niche pharma forums with strong sponsor support) and target audience (executives, regulators, investors), though typically focused on US/European markets.
• Arena International Events Group: Arena International organizes a portfolio of pharma, biotech, and life sciences conferences worldwide. Comparable to JackLeckerman in running paid B2B events with sponsorship-driven models and target audiences in pharma R&D, manufacturing, and regulatory affairs, although Arena's portfolio is broader and less biosimilar/niche-focused.
• GBIP Events (Global Biosimilar & Biologics Conference): GBIP Events organizes dedicated biosimilars and biologics conferences globally. It is a direct peer to JackLeckerman's Biosimilars LatAm franchise, sharing the same narrow biosimilar niche, regulator involvement, and C-level executive audience, though with a more international rather than Latin American emphasis.

Others

• MMS Holdings: MMS is a clinical research and regulatory services provider to pharma/biotech, including biosimilar sponsors. While not an event organizer, MMS is comparable to JackLeckerman's audience and ecosystem (biosimilar manufacturers, regulatory affairs professionals) and is an adjacent participant in the biosimilars knowledge community JackLeckerman convenes.

Broad incumbents

• Informa (CPHI): Informa is the world's largest events and B2B information group and runs CPHI, the flagship global pharma ingredients and manufacturing event series. It is comparable to JackLeckerman as a pharma-focused conference organizer, but at vastly larger scale and with a broader geographic footprint; both monetize through delegate passes, sponsorships, and pharma networking communities.
• Reuters Events (Pharma): Reuters Events organizes high-level pharma and life sciences conferences and awards, including the Reuters Events Pharma Awards. Comparable to JackLeckerman in targeting senior pharma executives with content-led, paid events and sponsorship opportunities, but with greater financial backing and broader geographic reach.
• BIO International Convention: BIO runs the BIO International Convention, the largest global biotech partnering conference with a focus on business development, licensing, and investment. Comparable to JackLeckerman in providing a pharma/biotech networking and business meeting platform, though at much larger scale and with broader biotech (not biosimilar-specific) coverage.
• Drug Information Association (DIA): DIA is a global, member-based association that runs major pharma, biotechnology, and regulatory conferences and training programs. It is comparable to JackLeckerman as a forum convening regulators, industry, and academics to discuss drug development and regulation, but operates at a much larger, association-based scale with broader therapeutic scope.

Emerging players

• World Drug Safety Congress: Organized by Terrapinn, this is a specialized pharma conference focused on pharmacovigilance and drug safety — one of the specific vertical topics JackLeckerman's forums cover (e.g., pharmacovigilance sessions within Biosimilars LatAm). Comparable as a paid pharma conference with regulator involvement, but more global in geographic focus and pharmacovigilance-specific.

Regional players

• PHARMAPRO: PharmaPro is a pharma industry event series operating in Spain/Latin America, focused on pharma manufacturing and supply chain. It is comparable to JackLeckerman in hosting pharma conferences with Latin American and European content, though more manufacturing-focused rather than biosimilar-regulatory.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/JackLeckerman
• Facebookfacebook.com/JackLeckerman
• LinkedInlinkedin.com/company/jack-leckerman
• Instagraminstagram.com/jackleckermanofficial

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JackLeckerman